AnaptysBio Inc (NAS:ANAB) Stock News, Headlines & Updates
AnaptysBio Inc Stock News from GuruFocus
- 1
May 09, 2024
Anaptys Announces First Quarter 2024 Financial Results and Provides Business Update
Marketwired • 4:00pm
Anaptys Announces Positive Top-Line GEMINI-2 Phase 3 Clinical Trial Results of Imsidolimab (IL-36R) in Generalized Pustular Psoriasis (GPP)
Marketwired • 4:00pm
Anaptys to Receive $50 Million in a Capped Non-Recourse Monetization from Amended Agreement with Sagard in Exchange for Additional Jemperli Royalties
Marketwired • 4:00pm
Apr 24, 2024
Actym Therapeutics Appoints Thomas Smart as CEO
PRNewswire • 9:00am
- 1
Show
Entries
Headlines
Total 0- 1
No recent news